TOP NEWS: AstraZeneca Boss Denounces "Me First" Approach To Covid Jabs

(Alliance News) - The boss of British-Swedish drugs giant AstraZeneca PLC, which with Oxford ...

Alliance News 25 January, 2021 | 2:45PM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - The boss of British-Swedish drugs giant AstraZeneca PLC, which with Oxford University has produced a Covid vaccine, denounced Monday a "me first" approach by some countries to obtaining doses.

AstraZeneca Chief Executive Pascal Soriot, speaking at a virtual event for the Davos World Economic Forum, also attacked a lack of global preparation for the deadly coronavirus pandemic.

The arrival of ground-breaking Covid-19 vaccines could have been grounds for celebrating, "but it unfortunately wasn't because there was a little bit of 'me first' behaviour", Soriot said.

"Globally, it is fair to say we could and should have been better prepared for this pandemic," he added.

Soriot noted however that "things are changing and international collaboration is emerging" over the coronavirus that has claimed the lives of more than two million people.

"There are many good examples of tremendous public-private collaboration actually in many countries," he said.

Going forward, "the first thing to do is to invest in prevention and early detection and early treatment," Soriot added.

He noted that among the world's most industrialised countries, only 3% of health expenditure is spent on prevention.

"Twenty percent of this 3.0%...is spent on immunisation and early detections of disease.

"So, essentially, we kind of tend to wait for people to become sick to try to address that, as opposed to early detecting (of) disease and preventing it."

source: AFP

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
AstraZeneca PLC 10,914.00 GBX 0.48

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures